脑卒中以其发病率高、复发率高、死亡率高、致残率高而成为学者研究的重点,随着其发病率的逐年上升以及该病给家庭带来的巨大经济负担和精神负担,脑卒中被越来越多的人们认识到是一个重要的、花费巨资的医疗及社会问题。但是脑卒中治疗状况仍不尽人意,至今仍没有一种药物被公认为对急性脑卒中具有确切疗效[1-2]。祖国医学有“风、劳、膨、膈”四大难证之称,其中中风被列为四大难症之首,可见无论是中医还是西医,从古到今,中风都是一大顽疾、难疾。 With its high incidence, high recurrence rate, high mortality rate and high morbidity rate, stroke has become the focus of scholars’ study. With the increasing incidence of stroke and the huge financial burden and mental burden brought by the disease, Stroke is recognized by an increasing number of people as an important and costly medical and social issue. However, the treatment of stroke remains unsatisfactory, and so far no single drug has been recognized as having an exact effect on acute stroke [1-2]. Chinese medicine has “wind, labor, swelling, diaphragm,” said the four dilemma, of which stroke was listed as the first four major difficulties, we can see both Chinese medicine or Western medicine, since ancient times, the stroke is a big Illness, hardship.